Strokes Averted by Intravenous Thrombolysis: A Secondary Analysis of a Prospective, Multicenter, Controlled Trial of Mobile Stroke Units

Author:

Navi Babak B.1ORCID,Bach Ivo2,Czap Alexandra L.2,Wang Mengxi3,Yamal Jose‐Miguel3,Jacob Asha P.2,Parker Stephanie A.2,Rajan Suja S.3ORCID,Mir Saad1,Sherman Carla1,Willey Joshua Z.4ORCID,Saver Jeffrey L.5,Gonzalez Michael O.3,Singh Noopur3,Jones William J.6,Ornelas David6,Gonzales Nicole R.6,Alexandrov Anne W.7,Alexandrov Andrei V.8,Nour May5,Spokoyny Ilana9,Mackey Jason10,Collins Sarah Q.10,Silnes Kelly11ORCID,Fink Mathew E.1,English Joey9,Barazangi Nobl9,Bratina Patti L.2,Volpi Jay12,Rao Chethan P. V.13,Griffin Laura14,Persse David15,Grotta James C.16

Affiliation:

1. Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute and Department of Neurology Weill Cornell Medicine New York NY

2. Department of Neurology UTHealth McGovern Medical School Houston TX

3. Department of Biostatistics and Data Science UTHealth School of Public Health Houston TX

4. Department of Neurology Columbia University Irving Medical Center New York NY

5. Department of Neurology Ronald Reagan UCLA Medical Center Los Angeles CA

6. Department of Neurology University of Colorado Aurora CO

7. Department of Neurology, College of Nursing and College of Medicine University of Tennessee Health Science Center Memphis TN

8. Department of Neurology University of Arizona, Banner University Medical Center Phoenix AZ

9. Department of Neurology Mills Peninsula Medical Center Burlingame CA

10. Department of Neurology Indiana University School of Medicine Indianapolis IN

11. University of Buckingham Medical School Buckingham UK

12. Department of Neurology Houston Methodist Hospital Houston TX

13. Department of Neurology Baylor College of Medicine Houston TX

14. HCA Houston Healthcare Houston TX

15. Department of Emergency Medicine Baylor College of Medicine Houston TX

16. Clinical Innovation and Research Institute, Memorial Hermann Hospital–Texas Medical Center Houston TX

Abstract

ObjectiveThis study was undertaken to examine averted stroke in optimized stroke systems.MethodsThis secondary analysis of a multicenter trial from 2014 to 2020 compared patients treated by mobile stroke unit (MSU) versus standard management. The analytical cohort consisted of participants with suspected stroke treated with intravenous thrombolysis. The main outcome was a tissue‐defined averted stroke, defined as a final diagnosis of stroke with resolution of presenting symptoms/signs by 24 hours attributed to thrombolysis and no acute infarction/hemorrhage on imaging. An additional outcome was stroke with early symptom resolution, defined as a final diagnosis of stroke with resolution of presenting symptoms/signs by 24 hours attributed to thrombolysis.ResultsAmong 1,009 patients with a median last known well to thrombolysis time of 87 minutes, 159 (16%) had tissue‐defined averted stroke and 276 (27%) had stroke with early symptom resolution. Compared with standard management, MSU care was associated with more tissue‐defined averted stroke (18% vs 11%, adjusted odds ratio [aOR] = 1.82, 95% confidence interval [CI] = 1.13–2.98) and stroke with early symptom resolution (31% vs 21%, aOR = 1.74, 95% CI = 1.12–2.61). The relationships between thrombolysis treatment time and averted/early recovered stroke appeared nonlinear. Most models indicated increased odds for stroke with early symptom resolution but not tissue‐defined averted stroke with earlier treatment. Additionally, younger age, female gender, hyperlipidemia, lower National Institutes of Health Stroke Scale, lower blood pressure, and no large vessel occlusion were associated with both tissue‐defined averted stroke and stroke with early symptom resolution.InterpretationIn optimized stroke systems, 1 in 4 patients treated with thrombolysis recovered within 24 hours and 1 in 6 had no demonstrable brain injury on imaging. ANN NEUROL 2024;95:347–361

Funder

Patient-Centered Outcomes Research Institute

Publisher

Wiley

Subject

Neurology (clinical),Neurology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3